Analyst Price Targets — SEM
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| May 12, 2026 8:12 pm | Ann Hynes | Mizuho Securities | $16.50 | $16.45 | TheFly | Select Medical downgraded to Neutral from Outperform at Mizuho |
| February 23, 2026 12:17 pm | — | RBC Capital | $19.00 | $15.01 | TheFly | Select Medical price target lowered to $19 from $20 at RBC Capital |
| November 3, 2025 11:37 am | Ann Hynes | Mizuho Securities | $17.00 | $13.83 | StreetInsider | Select Medical Holdings (SEM) PT Lowered to $17 at Mizuho |
| October 8, 2025 1:05 pm | — | RBC Capital | $20.00 | $15.21 | TheFly | Select Medical price target raised to $20 from $16 at RBC Capital |
| August 4, 2025 12:20 pm | — | UBS | $14.00 | $11.97 | TheFly | Select Medical price target lowered to $14 from $15 at UBS |
| May 6, 2024 6:38 am | Frank Morgan | RBC Capital | $40.00 | $31.43 | StreetInsider | Select Medical Holdings (SEM) PT Raised to $40 at RBC Capital |
Latest News for SEM
MECHANICSBURG, Pa., June 30, 2026 /PRNewswire/ -- Select Medical Holdings Corporation (the "Company" or "Select Medical," "we," "us," or "our") (NYSE: SEM) today announced the completion of its acquisition by an entity affiliated with a consortium led by Robert A.
MECHANICSBURG, Pa., June 26, 2026 /PRNewswire/ -- Select Medical Holdings Corporation (NYSE: SEM) ("Select Medical," "we," "us," or "our") confirmed today that its previously announced Agreement and Plan of Merger (the "Merger Agreement," and the transaction contemplated thereby, the "Merger") with an entity affiliated with a consortium led by Robert A.
NEW YORK, June 17, 2026 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces an investigation into Select Medical Holdings Corporation's (NYSE: SEM) board of directors and senior management for potential breaches of their fiduciary duties to shareholders in connection with the pending sale of the company for $16.50 per share as announced on March 2, 2026. If you are a current…
NEW YORK, June 15, 2026 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces an investigation into Select Medical Holdings Corporation's (NYSE: SEM) board of directors and senior management for potential breaches of their fiduciary duties to shareholders in connection with the pending sale of the company for $16.50 per share as announced on March 2, 2026. If you are a current…
/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
No Senate trades found for SEM.
U.S. House Trading
No House trades found for SEM.
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.